our Publications
2024
Developing enhanced immunotherapy using NKG2A knockout human pluripotent stem cell-derived NK cells
Staggered immunization with mRNA vaccines encoding SARS-CoV-2 polymerase or spike antigens broadens the T cell epitope repertoire
Targeting ABCG1 and SREBP-2 mediated cholesterol homeostasis ameliorates Zika virus-induced ocular pathology
Envelope protein-specific B cell receptors direct lentiviral vector tropism in vivo
Mpox Virus and its ocular surface manifestations
Innate immune pathway modulator screen identifies STING pathway activation as a strategy to inhibit multiple families of arbo and respiratory viruses.
Differential Susceptibility of Ex Vivo Primary Glioblastoma Tumors to Oncolytic Effect of Modified Zika Virus.
A ketogenic diet can mitigate SARS-CoV-2 induced systemic reprogramming and inflammation
Differential Susceptibility of Fetal Retinal Pigment Epithelial Cells, hiPSC- Retinal Stem Cells, and Retinal Organoids to Zika Virus Infection
2022
Replication-Deficient Zika Vector-Based Vaccine Provides Maternal and Fetal Protection in Mouse Model.
Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention.
Hippo signaling pathway activation during SARS-CoV-2 infection contributes to host antiviral response.
Compound screen identifies the small molecule Q34 as an inhibitor of SARS-CoV-2 infection.
Longitudinal Evaluation of Antibody Persistence in Mother-Infant Dyads After Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Pregnancy.
A CRISPR Activation Screen Identifies an Atypical Rho GTPase That Enhances Zika Viral Entry.
The systemic inflammatory landscape of COVID-19 in pregnancy: Extensive serum proteomic profiling of mother-infant dyads with in utero SARS-CoV-2.
SARS-CoV-2 and its beta variant of concern infect human conjunctival epithelial cells and induce differential antiviral innate immune response.
2021
A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection.
Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells.
SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery.
Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication.
SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition.
ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response.